← back to ranking

REGN · Regeneron Pharmaceuticals, Inc.

Biotechnology · mkt cap $62.1B · calls: Q1 FY2026 vs Q4 FY2025
3.0 conviction · conf-adj 3

conf –

triage_only:3.0

Enthusiasm latest / prev ()

No AI or ML discussion; focus is drugs, pipeline, and commercial execution